Mechanism of intranasal drug delivery directly to the brain

Crowe, Tyler P., Greenlee, M. Heather West, Kanthasamy, Anumantha G., Hsu, Walter H.·2018·Life Sciences

Cited by (721)

Items 301–400 of 721

  1. Improved drug transfer into brain tissue via the “nose-to-brain” approach using suspension or powder formulations based on the amorphous solid dispersion technique
    Susumu Suwabe, Tatsuaki Tagami, Koki Ogawa, Tetsuya Ozeki · 2023 · European Journal of Pharmaceutics and Biopharmaceutics
  2. Mitochondrial dysfunction and type I interferon signaling induce anxiodepressive-like behaviors in mice with neuropathic pain
    Natsuki Yoshimoto, Yoki Nakamura, Kazue Hisaoka‐Nakashima, Norimitsu Morioka · 2023 · Experimental Neurology
  3. Drug delivery of extracellular vesicles: Preparation, delivery strategies and applications
    Shang-Wen Lin, Jui‐Chen Tsai, Yan‐Jye Shyong · 2023 · International Journal of Pharmaceutics
  4. Intranasal Nanoparticulate Delivery Systems for Neurodegenerative Disorders: a Review
    Someshbabu Ramesh Babu, Harshith Hosahalli Shekara, Ashish Kumar Sahoo, Pyda Venkata Harsha Vardhan, Nitheesh Thiruppathi, Madhugiri Prakash Venkatesh · 2023 · Therapeutic Delivery
  5. Monoclonal antibody therapy for Alzheimer's disease focusing on intracerebral targets
    Xiaolei Gu, Qi Long, Qing Qi, Jing Zhou, Song Chen, Ling Wang · 2024 · BioScience Trends
  6. Polysaccharides: New Frontiers for Nasal Administration of Medicines
    Adryana Clementino, Giulia Climani, Annalisa Bianchera, Francesca Buttini, Fabio Sonvico · 2025 · Polysaccharides
  7. Nose-to-Brain Delivery of Dexamethasone: Biodistribution Studies in Mice
    Ivan Nicolás Pérez‐Osorio, Alejandro Espinosa, Manuel F. Giraldo-Velásquez, Patricia Padilla, Brandon Bárcena, Gladis Fragoso, Helgi Helene Jung-Cook, Hugo O. Besedovsky, Gabriela Meneses, Edda Lydia Sciutto Conde · 2021 · Journal of Pharmacology and Experimental Therapeutics
  8. Emerging Perspectives on Prime Editor Delivery to the Brain
    Eli BenDavid, Sina Ramezanian, Yaoyao Lu, Joël Rousseau, Avi Schroeder, Marc Lavertu, Jacques P. Tremblay · 2024 · Pharmaceuticals
  9. Extracellular vesicles released by glioblastoma cancer cells drive tumor invasiveness via Connexin-43 gap junctions
    Matteo Tamborini, Valentino Ribecco, Elisabetta Stanzani, Arianna Sironi, Monica Tambalo, Davide Franzone, Elena Maria Florio, Edoardo Fraviga, Chiara Saulle, Maria Cristina Gagliani et al. · 2025 · Neuro-Oncology
  10. Brain-targeted intranasal delivery of biologics: a perspective for Alzheimer's disease treatment
    Huan Li, Xiaoxia Shen, Beiyu Zhang, Yunan Li, Cameron Alexander, Peter Harvey, Zheying Zhu · 2025 · RSC Pharmaceutics
  11. Nose to brain delivery of ibudilast micelles for treatment of multiple sclerosis in an experimental autoimmune encephalomyelitis animal model
    Akram Sharifian, Jaleh Varshosaz, Mehdi Aliomrani, Mohammad Kazemi · 2023 · International Journal of Pharmaceutics
  12. Donepezil Brain and Blood Pharmacokinetic Modeling after Nasal Film and Oral Solution Administration in Mice
    Christos Kaikousidis, Paraskevi Papakyriakopoulou, Aristides Dokoumetzidis, Georgia N. Valsami · 2023 · Pharmaceutics
  13. Nose-to-brain delivery of perampanel formulated in a self-microemulsifying drug delivery system improves anticonvulsant and anxiolytic activity in mice
    Sara Meirinho, Márcio Rodrigues, Adriana O. Santos, Amílcar C. Falcão, Gilberto Alves · 2023 · International Journal of Pharmaceutics
  14. Research progress on intranasal treatment for Parkinson's disease
    Puyuan Wen, Chao Ren · 2024 · Neuroprotection/Neuroprotection (Chichester, England. Print)
  15. Cubosomes: evolving platform for intranasal drug delivery of neurotherapeutics
    Priyanka Gawarkar‐Patil, Bhavna Mahajan, Atmaram Pawar, Vividha S. Dhapte-Pawar · 2024 · Future Journal of Pharmaceutical Sciences
  16. Sirtuin 1 and Hormonal Regulations in Aging
    Milena Keremidarska‐Markova, Iliyana Sazdova, Mitko I. Mladenov, Bissera Pilicheva, Plamen Ivanov Zagorchev, Hristo Gagov · 2024 · Applied Sciences
  17. Potent therapeutic efficacy of intranasally deliverable paclitaxel modified with pH-sensitive and PEGylated polymeric micelle against glioblastoma
    Young Beom Kim, Soo‐Hwan Lee, Dayananda Kasala, Yuebin Zhao, Ao Jiao, JinWoo Hong, Jin Su Kim, Arum R. Yoon, Chae‐Ok Yun · 2025 · Journal of Controlled Release
  18. Nasal delivery of Fasudil‐modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis
    Shang‐De Guo, Chunyun Liu, Jingwen Yu, Zhi Chai, Qing Wang, Xi‐Ting Mi, Guobin Song, Yànhuá Lǐ, Peng‐Wei Yang, Ling Feng et al. · 2019 · CNS Neuroscience & Therapeutics
  19. Intranasal delivery of Paclitaxel encapsulated nanoparticles for brain injury due to Glioblastoma
    Ying Zhang, Chao Sun, Qingtao Zhang, Yongbing Deng, Xi Hu, Peng Chen · 2020 · Journal of Applied Biomaterials & Functional Materials
  20. Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models
    Weijun Wang, Steve D. Swenson, Hee‐Yeon Cho, Florence M. Hofman, Axel H. Schönthal, Thomas C. Chen · 2019 · Journal of neurosurgery
  21. Lyotropic Liquid Crystalline Based Nasal Spray for Improved Parkinson's Treatment: Enhanced Superior Nasal Tract Deposition and Antioxidation Strategy
    Xia Xiao, Ziqiao Zhong, Chunfu Wei, Guanlin Wang, Ziyu Zhao, Jingyu He, Zizhao Zhai, Yue Zhou, Wenhao Wang, Haihua Guo et al. · 2024 · Advanced Functional Materials
  22. The battle of lipid-based nanocarriers against blood-brain barrier: a critical review
    Kawthar K. Abla, Mohammed Maher Mehanna · 2023 · Journal of drug targeting
  23. Is Nasal Dysbiosis a Required Component for Neuroinflammation in Major Depressive Disorder?
    Jorge Manuel Vásquez-Pérez, Edith González‐Guevara, Diana Gutiérrez-Buenabad, Pablo Eliasib Martínez‐Gopar, Juan Carlos Martínez‐Lazcano, Graciela Cárdenas · 2024 · Molecular Neurobiology
  24. Early-Onset Molecular Derangements in the Olfactory Bulb of Tg2576 Mice: Novel Insights Into the Stress-Responsive Olfactory Kinase Dynamics in Alzheimer’s Disease
    Mercedes Lachén‐Montes, Andrea González-Morales, Maialen Palomino Alonso, Karina Ausín, Marta Gómez-Ochoa, María Victoria Zelaya, Isidró Ferrer, Alberto Pérez‐Mediavilla, Joaquín Fernández‐Irigoyen, Enrique Santamaría · 2019 · Frontiers in Aging Neuroscience
  25. Protective Effect of Insulin in Mouse Nasal Mucus Against Olfactory Epithelium Injury
    Shu Kikuta, Akihito Kuboki, Tatsuya Yamasoba · 2021 · Frontiers in Neural Circuits
  26. Gene Targeting to the Cerebral Cortex Following Intranasal Administration of Polyplexes
    Asya Petkova, Ilona Kubajewska, Alexandra Vaideanu, Andreas G. Schätzlein, Ijeoma Florence Uchegbu · 2022 · Pharmaceutics
  27. Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging
    Nisha Singh, Mattia Veronese, Jim O’Doherty, Teresa Sementa, Salvatore Bongarzone, Diana Cash, Camilla Simmons, Marco Arcolin, Paul K. Marsden, Antony D. Gee et al. · 2018 · Nuclear Medicine and Biology
  28. Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting
    Grishma N. Pawar, Neha N. Parayath, Aditya Sharma, Carlos Coito, Olga Khorkova, Jane H. Hsiao, William T. Curry, Mansoor M. Amiji, Benjamin Saul Bleier · 2021 · Frontiers in Pharmacology
  29. Modulation of olfactory area for effective transportation of actives in CNS disorders
    Harshvardhan Jain, Bala R. Prabhakar, Pravin K. Shende · 2022 · Journal of Drug Delivery Science and Technology
  30. From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics
    Tanaka, Masaru, Araujo, Adriano Cressoni, Valenti, Vítor Engrácia, Guiguer, Elen Landgraf, Catharin, Vitor Cavallari Strozze, Gualhardi, Cristiano Machado, de Souza Bastos Mazuqueli Pereira, Eliana, de Alvares Goulart, Ricardo, de Argolo Haber, Rafael Santos, de Carvalho, Atonelly Cassio Alves et al. · 2026 · International Journal of Molecular Sciences
  31. Nasal nanotherapeutics for central nervous system disorders: Bridging the translational gap in central nervous system drug delivery
    Yi-Bing Zhang, Mohan Liu, Yusi Wang, Die Hu, Siwen Wu, Binyan Zhao, Bailing Zhou, Li Yang · 2025 · European Journal of Pharmacology
  32. Intranasal Delivery of Rapamycin Via Brain-Targeting Polymeric Micelles for Alzheimer's Disease Treatment
    Vrashabh V. Sugandhi, Kranthi Gattu, Varsha Mundrathi, Rhema Khairnar, Tavinda Arshad, Sunil Kumar, Hyunah Cho · 2025 · International Journal of Pharmaceutics
  33. Microfluidic-Based Technologies for Crossing the Blood–Brain Barrier Against Alzheimer’s Disease: Novel Strategies and Challenges
    Irene Ferrari, Emanuele Limiti, Sara Maria Giannitelli, Marcella Trombetta, Alberto Rainer, Marcello D’Amelio, Livia La Barbera, Manuele Gori · 2025 · International Journal of Molecular Sciences
  34. Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain
    Gautham Gampa, Rahul Vadlakonda, Eric Gary Stefanich, Amrita V. Kamath, Shraddha Sadekar, Vittal Shivva · 2026 · Fluids and Barriers of the CNS
  35. The landscape of extracellular vesicles combined with intranasal delivery towards brain diseases
    Jiale Li, Hanwen Zhang, Yingyu Jiang, Nengjin Li, Anran Zhu, Yingjie Zhang, Kuanhan Feng, Wei Zeng, Liuqing Di, Ruoning Wang · 2024 · Nano Today
  36. Intranasal Therapy in Palliative Care
    Anna Ingielewicz, Robert K. Szymczak · 2024 · Pharmaceutics
  37. The novel anti-fibrillary effects of volatile compounds α-asarone and β-caryophyllene on tau protein: Towards promising therapeutic agents for Alzheimer's disease
    Afrooz Anbaraki, Zahra Dindar, Zahra Mousavi-Jarrahi, Atiyeh Ghasemi, Zahra Moeini, Mina Evini, Ali Akbar Saboury, Arefeh Seyedarabi · 2024 · International Journal of Biological Macromolecules
  38. Chitosan-coated nanoemulsion for the direct nose-to-brain delivery of sildenafil: Development and in vivo evaluation in a brain oxidative stress and inflammation model
    Ayman Salama, Ghareb M. Soliman, Nehal Mohsen Elsherbiny, Mohamed A. Safwat · 2024 · Journal of Drug Delivery Science and Technology
  39. Cyclodextrin inclusion complex and amorphous solid dispersions as formulation approaches for enhancement of curcumin’s solubility and nasal epithelial membrane permeation
    Carmen Schoeman, Suzanne Elaine Van Niekerk, Wilna Liebenberg, Josias Hendrik Hamman · 2024 · Future Journal of Pharmaceutical Sciences
  40. Serum Albumin in Nasal Drug Delivery Systems: Exploring the Role and Application
    Sandra Aulia Mardikasari, Gábor Katona, Ildikó Csóka · 2024 · Pharmaceutics
  41. A narrative review on potential applications of spanlastics for nose-to-brain delivery of therapeutically active agents
    Noorain Nadim, Ayub Ahmad Khan, Saba M. Khan, Rabea Parveen, Javed Ali · 2024 · Advances in Colloid and Interface Science
  42. Inhaled Lead Nanoparticles Enter the Brain through the Olfactory Pathway and Induce Neurodegenerative Changes Resembling Tauopathies
    Adriena Jedličková, Daniela Kristeková, Zuzana Husáková, Pavel Coufalík, Lucie Vrlíková, Tereza Smutná, Michaela Capandová, Lukáš Alexa, Denisa Lusková, Kamil Křůmal et al. · 2025 · ACS Nano
  43. Traditional Chinese Medicine in Emergency Treatment Mechanism and Application
    Meng Yu, Toby M. Michelena, Fangfang Cai, Xinfa Lou, Shasha Li, Ruifeng Zhang · 2020 · Open Access Emergency Medicine
  44. Direct transport theory: From the nose to the brain
    Namdev L. Dhas, Dattatraya Yadav, Ashutosh Kumar Singh, Atul Garkal, Ritu R. Kudarha, Priyanka Bangar, Jignasa Savjani, Chandrakantsing Vijaysing Pardeshi, Neha Garg, Tejal A Mehta · 2021 · Elsevier eBooks
  45. An effective PBPK model predicting dissolved drug transfer from a representative nasal cavity to the blood stream
    Sujal Dave, Clement Kleinstreuer, Sriram Chari · 2021 · Journal of Aerosol Science
  46. Development of thiolated polyethylene glycol-poly (lactic-co-glycolic acid) co-polymeric nanoparticles for intranasal delivery of quetiapine: in vitro–ex vivo characterization
    Dilip A. Patil, Sopan Nangare, Gaurav Patil, Kalpesh Nerkar, Ganesh Patil · 2022 · International Journal of Polymeric Materials
  47. Enhanced Brain Delivery via Intranasal Administration of Carbamazepine Loaded Solid Lipid Nanoparticles: Optimization, Pharmacokinetic Analysis, In-vitro, and In-vivo Drug Release Study
    Rajeshwar Kamal Kant Arya, Vijay Juyal, Dheeraj Bisht, Mohammad Rashid, Abdulmalik Saleh Alfawaz Altamimi, Obaid Afzal, Neeraj Kumar Sethiya · 2022 · Current Drug Delivery
  48. Distribution of insulin in primate brain following nose‐to‐brain transport
    Kylie R. Smith, Jinda Fan, Gwendolyn A. Marriner, John M. Gerdes, ROBERT M. KESSLER, Kurt R. Zinn · 2024 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  49. A Computational Systems Approach to Rational Design of Nose-to-Brain Delivery of Biopharmaceutics
    Costas A. Kiparissides, Athina C. Vasileiadou, Filippos F. Karageorgos, Stefania K. Serpetsi · 2019 · Industrial & Engineering Chemistry Research
  50. Central high mobility group box-1 induces mechanical hypersensitivity with spinal microglial activation in a mouse model of hemi-Parkinson’s disease
    Fumiaki Sato, Yoki Nakamura, Simeng Ma, Takahiro Kochi, Kazue Hisaoka‐Nakashima, Dengli Wang, Keyue Liu, Hidenori Wake, Masahiro Nishibori, Norimitsu Morioka · 2021 · Biomedicine & Pharmacotherapy
  51. Exploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis
    Maitrayee Ghosh, Debajyoti Roy, Shubham Thakur, Amrinder Singh · 2024 · Biopharmaceutics & Drug Disposition
  52. Intranasal Dexmedetomidine for the Management of Preoperative Anxiety-Related Insomnia: A Randomized, Three-Blinded, Clinical Trial Compared with Lorazepam and Placebo
    Wen‐Yi Yang, Kuan-Ta Huang, Zhi-jian Lin, Wen Zeng, Xin Liu, Hong-Bo Liu, Maolin Zhong, Jun Wei, Weidong Liang, Li-feng Wang et al. · 2024 · Drug Design Development and Therapy
  53. Advancements in nose-to-brain drug targeting for Alzheimer’s disease: a review of nanocarriers and clinical insights
    Kumari Komal, Rashmi Ghosh, Debayan Sil, Rohit Sharma, Sourabh Kumar, Prachi Pandey, Manish Kumar · 2025 · Inflammopharmacology
  54. Albumin antagonizes Alzheimer’s disease-related Tau pathology and enhances cognitive performance by inhibiting aberrant Tau aggregation
    Mingxuan Yang, Zhipeng Wang, Yanli Zhang, Zhina Zhang, Yanli Li, Rui Wang, Qiang Su, Junhong Guo · 2025 · Experimental Neurology
  55. Intranasal drug delivery: Pathways, challenges, and advancements in CNS targeting
    Noura Al‐Hajaj, Reem Khalil, Ghaleb A. Husseini · 2025 · Journal of Drug Delivery Science and Technology
  56. Venlafaxine-plga nanoparticles provide a fast onset of action in an animal model of depression via nose-to-brain.
    M. D. Cayero-Otero, L. Perez-Caballero, Irene Suarez-Pereira, María Hidalgo-Figueroa, A. Delgado-Sequera, J. M. Montesinos, E. Berrocoso, L. Martín-Banderas · 2025 · International journal of pharmaceutics
  57. Preclinical Nanomedicines for Polyglutamine-Based Neurodegenerative Diseases
    Leo Kit Cheung Lee, Lok I Leong, Yao Liu, Meihua Luo, Ho Yin Edwin Chan, Chung Hang Jonathan Choi · 2020 · Molecular Pharmaceutics
  58. Dynorphin A (1–8) inhibits oxidative stress and apoptosis in MCAO rats, affording neuroprotection through NMDA receptor and κ-opioid receptor channels
    Mengying Chen, Xiaodong Zhang, Jiaxin Fan, Hong Bing Sun, Qingling Yao, Jinming Shi, Huiyang Qu, Shuang Du, Yuxuan Cheng, Shuyin Ma et al. · 2021 · Neuropeptides
  59. Intranasal administration of fingolimod (FTY720) attenuates demyelination area in lysolecithin-induced demyelination model of rat optic chiasm
    Maryam Ghasemi‐Kasman, Nasrin Nosratiyan, Mona Hashemian, Seyyed-Raheleh Ahmadian, Hadi Parsian, Sahar Rostami-Mansoor · 2022 · Multiple Sclerosis and Related Disorders
  60. Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer
    Tobeka Naki, Blessing A. Aderibigbe · 2022 · Pharmaceutics
  61. A comprehensive review on carrier mediated nose to brain targeting: emphasis on molecular targets, current trends, future prospects, and challenges
    Suman Tomar, Rakesh Kumar Yadav, Kamal Shah, Hitesh Kumar Dewangan · 2022 · International Journal of Polymeric Materials
  62. An in vitro and in vivo study of the brain-targeting effects of an epidermal growth factor-functionalized cholera toxin-like chimeric protein
    Huafeng He, Danmin Lin, Jiajie Sun, Xianying He, Tiantian Wang, Yinglin Fang, Yijun Liu, Kaixiang Fan, Xinxin Chen, Huahong He et al. · 2020 · Journal of Controlled Release
  63. Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps
    Rajesh Kumar, Monica Gulati, Sachin Kumar Singh, Deepika Sharma, Omji Porwal · 2020 · CNS & Neurological Disorders - Drug Targets
  64. Formulation optimization of smart thermosetting lamotrigine loaded hydrogels using response surface methodology, box benhken design and artificial neural networks
    Siyabonga Melamane, Roderick B. Walker, Sandile Maswazi Khamanga · 2020 · Drug Development and Industrial Pharmacy
  65. Diet-Induced Obesity Disrupts Trace Element Homeostasis and Gene Expression in the Olfactory Bulb
    Melissa S. Totten, Derek M. Pierce, Keith M. Erikson · 2020 · Nutrients
  66. Bioinspired nanocarriers for advanced drug delivery
    Kalyani Pathak, Mohammad Zaki Ahmad, Jon Jyoti Sahariah, Manisha Sahariah, Surajit Konwar, Banasri Talukdar, Aparoop Das, Partha Protim Borthakur, Ankur Gogoi · 2025 · Nano Express
  67. Intranasal delivery of iron chelators and management of central nervous system disease
    Ruiying Cheng, Jonghan Kim · 2025 · Frontiers in Pharmacology
  68. Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review
    Archita Kapoor, Abdul Hafeez, Poonam Kushwaha · 2023 · Current Drug Delivery
  69. Nose-to-Brain delivery of antiretroviral drug loaded lipidic nanocarriers to purge HIV reservoirs in CNS: A safer approach
    Sonal Mehrotra, Salwa, Pavan Kalyan BG, Navya Ajitkumar Bhaskaran, Srinivas Reddy Jitta, Lalit Kumar · 2023 · Journal of Drug Delivery Science and Technology
  70. Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions
    Nitish Kumar, Bharat Khurana, Daisy Arora · 2023 · Pharmaceutical Development and Technology
  71. Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders
    Pratik Chakraborty, Chiranjib Bhattacharyya, Ranabir Sahu, Tarun Kumar Dua, Ramesh J. L. Kandimalla, Saikat Dewanjee · 2023 · Journal of Drug Delivery Science and Technology
  72. Innovation in nanomedicine: nanocarriers for central nervous system disorders management
    Muhammad Ahsan Waqar, Naeem Mubarak, Asad Majeed Khan, Shakeel Ahmad, Maryam Zaib, Uroosa Kanwal, Iqra Noor Khan, Maryam Ayesha, Maryam Mughal, Muhammad Fahad · 2024 · International Journal of Polymeric Materials
  73. In Silico Study to Enhance Delivery Efficiency of Charged Nanoscale Nasal Spray Aerosols to the Olfactory Region Using External Magnetic Fields
    Benjamin C. Li, Yu Feng · 2022 · Bioengineering
  74. Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma
    Takahiro Sasaki, Jun Watanabe, Xingyao He, Hiroaki Katagi, Amreena Suri, Yukitomo Ishi, Kouki Abe, Manabu Natsumeda, William H. Frey, Peng Zhang et al. · 2022 · Journal of neurosurgery
  75. Formulation Considerations for Improving Intranasal Delivery of CNS Acting Therapeutics
    Darshana Patel, Hetal Paresh Thakkar · 2022 · Therapeutic Delivery
  76. Antinociceptive and anxiolytic-like effects of Lavandula angustifolia essential oil on rat models of orofacial pain
    Vanessa Bordenowsky Pereira Lejeune, Raphael Vieira Lopes, Darciane Favero Baggio, Laura de Oliveira Koren, Janaína Menezes Zanoveli, Juliana Geremias Chichorro · 2022 · Journal of Applied Oral Science
  77. Natural essential oils derived from herbal medicines: A promising therapy strategy for treating cognitive impairment
    Ai Shi, Yu Long, Yin Ma, Shuang Yu, Dan Li, Jie Deng, Jing Wen, Xiaoqiu Li, Yuanyuan Wu, Xiaofang He et al. · 2023 · Frontiers in Aging Neuroscience
  78. Intranasally Administered MSC-Derived Extracellular Vesicles Reverse Cisplatin-Induced Cognitive Impairment
    Bojana S. Milutinovic, Rajasekaran Mahalingam, Mayela Carolina Mendt, Luis Arroyo, Alexandre V. Seua, Shruti Dharmaraj, Elizabeth J. Shpall, Cobi J. Heijnen · 2023 · International Journal of Molecular Sciences
  79. Intranasal delivery of Thyroid hormones in MCT8 deficiency
    Carmen Grijota-Martínez, Soledad Bárez‐López, Eva Ausó, Samuel Refetoff, William H. Frey, Ana Guadaño‐Ferraz · 2020 · PLoS ONE
  80. Glucagon for hypoglycaemia treatment in type 1 diabetes
    Ajenthen Gayathri Ranjan, Signe Schmidt, Kirsten Nørgaard · 2020 · Diabetes/Metabolism Research and Reviews
  81. Postnatal therapeutic approaches in genetic neurodevelopmental disorders
    Gilad Levy, Boaz Barak · 2020 · Neural Regeneration Research
  82. Insulin Analogues with Altered Insulin Receptor Isoform Binding Specificities and Enhanced Aggregation Stabilities
    Terezie Páníková, Katarína Mitrová, Tereza Halamová, Karolína Mrzílková, Jan Pícha, Martina Chrudinová, Andrii S. Kurochka, Irena Selicharová, Lenka Žáková, Jiřı́ Jiráček · 2021 · Journal of Medicinal Chemistry
  83. Nanoparticle-Mediated Nose-to-Brain Delivery for Ischemic Stroke Therapy: Preclinical Insights
    Joonhyuck Park, Tae‐Ryong Riew · 2025 · Pharmaceutics
  84. Advances in Intranasal Delivery of Exosomes for Central Nervous System Disorders
    Babak Arjmand, Ali Reza Mojavezi, Amirhossein Kamroo, Rosa Kalami Yazdi, Mostafa Rezaei–Tavirani, Mohamad-Sadegh Vahedi · 2025 · Molecular Neurobiology
  85. Advances in nanocarrier-based nose-to-brain drug delivery systems for neurological disorders - A comprehensive review
    Hesam Kamyab, Sajad Jamalpour, Elham Khalili, Saravanan Rajendran · 2026 · Powder Technology
  86. Intranasal Nano-Delivery Systems: Emerging Strategies for Central Nervous System Disease Therapeutics
    Tong Gao, Qihui Chu, Xiaomin Xing, Yuefen Liu, Shunli Fu, Donghua Liu · 2026 · International Journal of Nanomedicine
  87. An Ex vivo Investigation on Drug Permeability of Sheep Nasal Epithelial Tissue Membranes from the Respiratory and Olfactory Regions
    Anja Haasbroek‐Pheiffer, Alvaro M. Viljoen, Jan Harm Steenekamp, Weiyang Chen, Josias Hendrik Hamman · 2022 · Current Drug Delivery
  88. A Dual Therapy of Nanostructured Lipid Carrier Loaded with Teriflunomide—A Dihydro-Orotate Dehydrogenase Inhibitor and an miR-155-Antagomir in Cuprizone-Induced C57BL/6J Mouse
    Trideva Sastri Koduru, N. Vishal Gupta, Balamuralidhara Veeranna, S Shanmuganathan · 2023 · Pharmaceutics
  89. Intranasal delivery of chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: A comprehensive review of advanced strategies for CNS targeting
    Rabab M. Ibrahim, Mahmoud H. M. Teaima, Mohamed A. El-Nabarawi, Noha M. Badawi · 2024 · Journal of Drug Delivery Science and Technology
  90. Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy
    Gulshan Sharma, Karan Wadhwa, Shobhit Kumar, Govind Singh, Rakesh Pahwa · 2025 · Drug Delivery and Translational Research
  91. Peptide therapeutics: current status and future opportunity with focus on nose-to-brain delivery☆
    Eva‐Maria Jülke, Annette Gabriele Beck‐Sickinger · 2025 · Peptides
  92. Intranasal insulin enhances postoperative sleep quality and delirium in middle-aged cardiac surgery patients: A randomized controlled trial
    Ming Yang, Tong Lu, Lei Cao, Cheng Xiao, Yan Liang, Jinping Ding, Xuetao Jiang, Wei Wang, Fang Chen, Zhiyong Du et al. · 2025 · Sleep Medicine
  93. Advancements in Nanotherapeutics for the Treatment of Depression via Intranasal Pathway: A Review
    Meenakshi Bhavesh Patel, Vahid Vikram Minglani, Hatasha Vaddadi, Lalit Lata Jha, Laxmanbhai Patel, Kampanart Huanbutta, Tanikan Sangnim · 2025 · International Journal of Nanomedicine
  94. Engineered inhalable nanocatalytic therapeutics for Parkinson's disease by inducing mitochondrial autophagy
    Mingming Guo, Bowen Li, Guoqing Feng, Xin Su, Xue Wang, Xiaoxuan Han, Manyi Yang, Lipeng Bai, Xiaodong Zhu, Haojun Fan et al. · 2023 · Materials & Design
  95. Therapeutic potential of thymoquinone and its nanoformulations in neuropsychological disorders: a comprehensive review on molecular mechanisms in preclinical studies
    Maryam Saadat, Narjes Dahmardeh, Fatemeh Sheikhbahaei, Tahmineh Mokhtari · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
  96. Enhanced brain distribution of Ginsenoside F1 via intranasal administration in combination with absorption enhancers
    Ying Mao, Weihua Yuan, Jiayi Gai, Yixuan Zhang, Shiwen Wu, Enyu Xu, Luyao Wang, Xin Zhang, Jian Guan, Shirui Mao · 2024 · International Journal of Pharmaceutics
  97. Influence of odor environments on cognitive efficiency: A comprehensive review
    Hao Cai, Hanlin Xiao, Chengxin Tong, Xian Dong, Shilong Chen, Feng Xu · 2024 · The Science of The Total Environment
  98. Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme
    Ankit Kumar, Rahul Shukla · 2024 · Journal of Biomaterials Science Polymer Edition
  99. A Breath of Fresh Air: Perspectives on Inhaled Nutrients and Bacteria to Improve Human Health
    Flávia Fayet‐Moore, Stephen R. Robinson · 2024 · Advances in Nutrition
  100. Technological Strategies Applied to Pharmaceutical Systems for Intranasal Administration of Drugs Intended for Neurological Treatments: A Review
    Maria Vitoria Gouveia Botan, Jéssica Bassi da Silva, Marcos Luciano Bruschi · 2024 · AAPS PharmSciTech